CEMEX, S.A.B. de C.V. (NYSE:CX) Receives $7.82 Consensus Target Price from Analysts

CEMEX, S.A.B. de C.V. (NYSE:CX) has earned a consensus rating of “Hold” from the seven analysts that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year target price among analysts that have covered the stock in the last year is $7.82.

A number of equities analysts have issued reports on the company. Morgan Stanley downgraded CEMEX from an “overweight” rating to an “equal weight” rating in a research note on Wednesday, March 26th. Royal Bank of Canada lifted their target price on CEMEX from $5.00 to $6.00 and gave the company an “underperform” rating in a research report on Monday, February 10th. StockNews.com lowered CEMEX from a “buy” rating to a “hold” rating in a research report on Tuesday. Finally, The Goldman Sachs Group lifted their price objective on shares of CEMEX from $8.00 to $9.00 and gave the stock a “buy” rating in a report on Thursday, February 27th.

Hedge Funds Weigh In On CEMEX

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Stifel Financial Corp raised its position in CEMEX by 30.4% in the third quarter. Stifel Financial Corp now owns 100,406 shares of the construction company’s stock worth $612,000 after acquiring an additional 23,388 shares during the period. Orion Portfolio Solutions LLC raised its holdings in shares of CEMEX by 39.9% in the 3rd quarter. Orion Portfolio Solutions LLC now owns 15,087 shares of the construction company’s stock worth $92,000 after purchasing an additional 4,306 shares during the period. MML Investors Services LLC lifted its stake in CEMEX by 65.8% in the third quarter. MML Investors Services LLC now owns 20,706 shares of the construction company’s stock valued at $126,000 after purchasing an additional 8,221 shares during the last quarter. Public Employees Retirement System of Ohio bought a new position in CEMEX during the third quarter valued at $9,037,000. Finally, Barclays PLC grew its holdings in CEMEX by 41.8% during the third quarter. Barclays PLC now owns 6,249 shares of the construction company’s stock valued at $38,000 after purchasing an additional 1,843 shares during the period. 82.97% of the stock is owned by hedge funds and other institutional investors.

CEMEX Trading Up 3.1 %

NYSE CX opened at $5.18 on Wednesday. The company has a quick ratio of 0.58, a current ratio of 0.82 and a debt-to-equity ratio of 0.43. CEMEX has a 52 week low of $4.89 and a 52 week high of $8.73. The business has a 50 day moving average price of $6.05 and a 200-day moving average price of $5.82. The company has a market cap of $7.50 billion, a price-to-earnings ratio of 8.21 and a beta of 1.28.

CEMEX (NYSE:CX) last posted its quarterly earnings results on Thursday, February 13th. The construction company reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.10 by $0.06. CEMEX had a net margin of 5.70% and a return on equity of 7.78%. As a group, equities analysts expect that CEMEX will post 0.69 earnings per share for the current fiscal year.

CEMEX Announces Dividend

The firm also recently announced a dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a dividend of $0.0207 per share. The ex-dividend date was Monday, March 10th. CEMEX’s dividend payout ratio is presently 12.70%.

About CEMEX

CEMEX, SAB. de C.V., together with its subsidiaries, produces, markets, distributes, and sells cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and services worldwide. The company offers gray ordinary portland, white portland, oil-well, and blended cement products; mortar; and standard ready-mix, architectural and decorative, rapid-setting, fiber-reinforced, fluid-fill, roller-compacted, self-consolidating, pervious, and antibacterial, and other concrete products.